These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16945375)

  • 1. Nicotinic acid induces secretion of prostaglandin D2 in human macrophages: an in vitro model of the niacin flush.
    Meyers CD; Liu P; Kamanna VS; Kashyap ML
    Atherosclerosis; 2007 Jun; 192(2):253-8. PubMed ID: 16945375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid.
    Morrow JD; Parsons WG; Roberts LJ
    Prostaglandins; 1989 Aug; 38(2):263-74. PubMed ID: 2475889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The flavonoid luteolin inhibits niacin-induced flush.
    Papaliodis D; Boucher W; Kempuraj D; Theoharides TC
    Br J Pharmacol; 2008 Apr; 153(7):1382-7. PubMed ID: 18223672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous fatty acids and niacin on acute prostaglandin D
    Montserrat-de la Paz S; Bermudez B; Lopez S; Naranjo MC; Romero Y; Bando-Hidalgo MJ; Abia R; Muriana FJG
    J Nutr Biochem; 2017 Jan; 39():22-31. PubMed ID: 27741434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Niacin-induced "flush" involves release of prostaglandin D2 from mast cells and serotonin from platelets: evidence from human cells in vitro and an animal model.
    Papaliodis D; Boucher W; Kempuraj D; Michaelian M; Wolfberg A; House M; Theoharides TC
    J Pharmacol Exp Ther; 2008 Dec; 327(3):665-72. PubMed ID: 18784348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quercetin containing supplement reduces niacin-induced flush in humans.
    Kalogeromitros D; Makris M; Chliva C; Aggelides X; Kempuraj D; Theoharides TC
    Int J Immunopathol Pharmacol; 2008; 21(3):509-14. PubMed ID: 18831918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of aspirin when added to the prostaglandin D2 receptor antagonist laropiprant on niacin-induced flushing symptoms.
    Dishy V; Liu F; Ebel DL; Atiee GJ; Royalty J; Reilley S; Paolini JF; Wagner JA; Lai E
    J Clin Pharmacol; 2009 Apr; 49(4):416-22. PubMed ID: 19246721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells.
    Benyó Z; Gille A; Bennett CL; Clausen BE; Offermanns S
    Mol Pharmacol; 2006 Dec; 70(6):1844-9. PubMed ID: 17008386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans.
    Cheng K; Wu TJ; Wu KK; Sturino C; Metters K; Gottesdiener K; Wright SD; Wang Z; O'Neill G; Lai E; Waters MG
    Proc Natl Acad Sci U S A; 2006 Apr; 103(17):6682-7. PubMed ID: 16617107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans.
    Morrow JD; Awad JA; Oates JA; Roberts LJ
    J Invest Dermatol; 1992 May; 98(5):812-5. PubMed ID: 1373750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Langerhans cells release prostaglandin D2 in response to nicotinic acid.
    Maciejewski-Lenoir D; Richman JG; Hakak Y; Gaidarov I; Behan DP; Connolly DT
    J Invest Dermatol; 2006 Dec; 126(12):2637-46. PubMed ID: 17008871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotinic acid (niacin): new lipid-independent mechanisms of action and therapeutic potentials.
    Lukasova M; Hanson J; Tunaru S; Offermanns S
    Trends Pharmacol Sci; 2011 Dec; 32(12):700-7. PubMed ID: 21944259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin synthase 1 and prostaglandin synthase 2 both participate in activation-induced prostaglandin D2 production in mast cells.
    Kawata R; Reddy ST; Wolner B; Herschman HR
    J Immunol; 1995 Jul; 155(2):818-25. PubMed ID: 7608559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of soluble epoxide hydrolase limits niacin-induced vasodilation in mice.
    Inceoglu AB; Clifton HL; Yang J; Hegedus C; Hammock BD; Schaefer S
    J Cardiovasc Pharmacol; 2012 Jul; 60(1):70-5. PubMed ID: 22526297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of prostaglandin D2 and the autonomic nervous system in niacin-induced flushing.
    Parson HK; Harati H; Cooper D; Vinik AI
    J Diabetes; 2013 Mar; 5(1):59-67. PubMed ID: 22727040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Niacin Promotes Cardiac Healing after Myocardial Infarction through Activation of the Myeloid Prostaglandin D
    Kong D; Li J; Shen Y; Liu G; Zuo S; Tao B; Ji Y; Lu A; Lazarus M; Breyer RM; Yu Y
    J Pharmacol Exp Ther; 2017 Mar; 360(3):435-444. PubMed ID: 28057839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Niacin use and cutaneous flushing: mechanisms and strategies for prevention.
    Davidson MH
    Am J Cardiol; 2008 Apr; 101(8A):14B-19B. PubMed ID: 18375236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release.
    Holgate ST; Burns GB; Robinson C; Church MK
    J Immunol; 1984 Oct; 133(4):2138-44. PubMed ID: 6206153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinic acid (niacin) receptor agonists: will they be useful therapeutic agents?
    Kamanna VS; Kashyap ML
    Am J Cardiol; 2007 Dec; 100(11 A):S53-61. PubMed ID: 18047854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of markedly increased quantities of prostaglandin D2 from the skin in vivo in humans following the application of sorbic acid.
    Morrow JD; Minton TA; Awad JA; Roberts LJ
    Arch Dermatol; 1994 Nov; 130(11):1408-12. PubMed ID: 7979442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.